8826 - 8850 of 9104 Results
Title
Year
-
OPENTitle: α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page: 69End Page: 69Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-024-00756-2Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-024-00756-2Citation Count: 70
-
OPENTitle: Single-cell somatic copy number variants in brain using different amplification methods and reference genomesJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 1288End Page: 1288Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s42003-024-06940-wBest OA location URL: https://www.nature.com/articles/s42003-024-06940-w.pdfCitation Count: 8
-
OPENTitle: Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse modelsJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 35Issue #: 3Start Page: 102251End Page: 102251Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2024.102251Best OA location URL: https://doi.org/10.1016/j.omtn.2024.102251Citation Count: 8
-
OPENTitle: Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 9Start Page: 1103End Page: 1112Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.14145Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.14145Citation Count: 10
- Direct and indirect regulation of β-glucocerebrosidase by the transcription factors USF2 and ONECUT22024OPENTitle: Direct and indirect regulation of β-glucocerebrosidase by the transcription factors USF2 and ONECUT2Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 192End Page: 192Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00819-7Best OA location URL: https://www.nature.com/articles/s41531-024-00819-7.pdfCitation Count: 3
-
OPENTitle: The Black and African American Connections to Parkinson’s Disease (BLAAC PD) study protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page: 403End Page: 403Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03914-7Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-024-03914-7Citation Count: 3
-
OPENTitle: AI-based differential diagnosis of dementia etiologies on multimodal dataJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 10Start Page: 2977End Page: 2989Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03118-zBest OA location URL: https://www.nature.com/articles/s41591-024-03118-z.pdfCitation Count: 153
-
OPENTitle: High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: National Academy of SciencesVol: 121Issue #: 42Start Page: e2406009121End Page: e2406009121Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2406009121Best OA location URL: https://www.pnas.org/doi/pdf/10.1073/pnas.2406009121Citation Count: 22
- Investigating the Protective Role of the Mitochondrial 2158 T > C Variant in Parkinson's Disease2024OPENTitle: Investigating the Protective Role of the Mitochondrial 2158 T > C Variant in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 9Start Page: 1645End Page: 1647Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29892Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29892Citation Count: 2
-
OPENTitle: Medication recommendation for Parkinson’s disease based on dynamics of symptom progressionJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 25051End Page: 25051Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-024-76941-6Best OA location URL: https://www.nature.com/articles/s41598-024-76941-6.pdfCitation Count: 2
-
OPENTitle: Oral and gut microbiome profiles in people with early idiopathic Parkinson’s diseaseJournal Name: Communications MedicinePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page: 209End Page: 209Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s43856-024-00630-8Best OA location URL: https://doi.org/10.1038/s43856-024-00630-8Citation Count: 9
-
OPENTitle: Are rare heterozygous SYNJ1 variants associated with Parkinson’s disease?Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 201End Page: 201Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00809-9Best OA location URL: https://www.nature.com/articles/s41531-024-00809-9.pdfCitation Count: 3
-
OPENTitle: Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 202End Page: 202Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00805-zBest OA location URL: https://www.nature.com/articles/s41531-024-00805-z.pdfCitation Count: 5
-
OPENTitle: Randomized crossover trial on motor and non-motor outcome of directional deep brain stimulation in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 204End Page: 204Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00812-0Best OA location URL: https://www.nature.com/articles/s41531-024-00812-0.pdfCitation Count: 10
-
OPENTitle: ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer’s disease through BDNF/NGFR signalingJournal Name: Cell GenomicsPublisher: Elsevier BVVol: 4Issue #: 9Start Page: 100642End Page: 100642Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.xgen.2024.100642Best OA location URL: https://doi.org/10.1016/j.xgen.2024.100642Citation Count: 15
-
OPENTitle: α-synuclein overexpression and the microbiome shape the gut and brain metabolome in miceJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 208End Page: 208Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00816-wBest OA location URL: https://www.nature.com/articles/s41531-024-00816-w.pdfCitation Count: 10
-
OPENTitle: ScRNAbox: empowering single-cell RNA sequencing on high performance computing systemsJournal Name: BMC BioinformaticsPublisher: Springer Science and Business Media LLCVol: 25Issue #: 1Start Page: 319End Page: 319Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12859-024-05935-yBest OA location URL: https://link.springer.com/content/pdf/10.1186/s12859-024-05935-y.pdfCitation Count: 4
-
OPENTitle: An interpretable deep learning framework identifies proteomic drivers of Alzheimer’s diseaseJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 1379984End Page: 1379984Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2024.1379984Best OA location URL: https://public-pages-files-2025.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2024.1379984/pdfCitation Count: 8
-
OPENTitle: Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficitsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 8819End Page: 8819Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-53168-7Best OA location URL: https://www.nature.com/articles/s41467-024-53168-7.pdfCitation Count: 31
-
OPENTitle: Associations between Sleep Disorders and Impulsive-Compulsive Behaviors in Parkinson’s Disease: A Prospective Cohort StudyJournal Name: NeuroepidemiologyPublisher: S. Karger AGVol: 58Issue #: 4Start Page: 256End Page: 263Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1159/000536555Best OA location URL: https://doi.org/10.1159/000536555Citation Count: 5
-
OPENTitle: Naturally occurring hyperactive variants of human parkinJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 961End Page: 961Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s42003-024-06656-xBest OA location URL: https://www.nature.com/articles/s42003-024-06656-x.pdfCitation Count: 4
-
OPENTitle: Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson diseaseJournal Name: Nature Mental HealthPublisher: Springer Science and Business Media LLCVol: 2Issue #: 8Start Page: 916End Page: 923Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s44220-024-00256-8Best OA location URL: https://www.nature.com/articles/s44220-024-00256-8.pdfCitation Count: 10
-
OPENTitle: LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesiasJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 53End Page: 53Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-016-0234-2Best OA location URL: https://molecularbrain.biomedcentral.com/track/pdf/10.1186/s13041-016-0234-2Citation Count: 13
-
OPENTitle: Predictive Big Data Analytics: A Study of Parkinson’s Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete ObservationsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 8Start Page: e0157077End Page: e0157077Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0157077Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0157077&type=printableCitation Count: 146
-
OPENTitle: Genetic analysis and natural history of Parkinson’s disease due to the LRRK2 G2019S variantJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 6Start Page: 1996End Page: 2008Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awae073Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae073/57762235/awae073.pdfCitation Count: 50